Morinda citrifolia (Noni) alters oxidative stress marker and antioxidant activity in cervical cancer cell lines

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 8, 2013, Pages 4603-4606

  Gupta, Rakesh Kumar ^a   Singh, Neeta ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Catalase; Cisplatin; HeLa; Malondialdehyde; Morinda citrifolia (Noni); SiHa

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CATALASE; CISPLATIN; MALONALDEHYDE; PLANT EXTRACT;

ARTICLE; CHEMISTRY; DRUG EFFECT; FEMALE; HUMAN; METABOLISM; MORINDA; OXIDATIVE STRESS; PATHOLOGY; PHYTOTHERAPY; TUMOR CELL CULTURE; UTERINE CERVIX TUMOR; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; BLOTTING, WESTERN; CATALASE; CISPLATIN; FEMALE; HUMANS; MALONDIALDEHYDE; MORINDA; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 84885723840     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.8.4603     Document Type: Article

References (18)

1. Alitheen NB, Manaf AA, Yeap SK, et al (2010). Immunomodulatory effects of damnacanthal isolated from roots of Morinda elliptica. Pharm Biol, 48, 446-52.
2. Alshatwi AA, Shafi G, Hasan TN, et al (2011). Apoptosis-mediated inhibition of human breast cancer cell proliferation by lemon citrus extract. Asian Pac J Cancer Prev, 12, 1555-9.
3. Borek C (2004b). Dietary antioxidants and human cancer. Integr Cancer Ther, 3, 333-41.
4. Bulló M, Lamuela-Raventós R, Salas-Salvadó J (2011). Mediterranean diet and oxidation: nuts and olive oil as important sources of fat and antioxidants. Curr Top Med Chem, 11, 1797-810.
5. Gupta RK, Banerjee A, Pathak S, et al (2013). Induction of mitochondrial-mediated apoptosis by morinda citrifolia (noni) in human cervical cancer cells. Asian Pac J Cancer Prev, 14, 237-42.
6. Gupta RK, Patel AK, Kumari R, et al (2012). Interaction between oxidative stress, lipid profile and antioxidants in breast cancer: a case-control study. Asian Pac J Cancer Prev, 13, 6295-8.
7. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
8. Hernandez-Flores G, Ortiz-Lazareno PC, Lerma-Diaz JM, et al (2011). Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescence. BMC Cancer, 11, 483.
9. Kostova I (2006). Platinum complexes as anticancer agents. recent patents on anti-cancer. Drug Discovery, 1, 1-22.
10. Ma DL, West BJ, Su CX, et al (2007). Evaluation of the ergogenic potential of noni juice. Phytother Res, 21, 1100-1.
11. Mohd-Zin Z, Abdul-Hamid A, Osman A (2002). Antioxidative activity of extracts from Mengkudu (Morinda citrifolia L.) root, fruit and leaf. Food Chem, 78, 227-31.
12. Pathak S, Bhatla N, Singh N (2012). Cervical cancer pathogenesis is associated with one carbon metabolism. Mol Cell Biochem, 369, 1-7.
13. Peerapatdit T, Patchanans N, Likidlilid A, Poldee S, Sriratanasathavorn C (2006). Plasma lipid peroxidation and antioxidiant nutrients in Type 2 Diabetic patients. J Med Assoc Thai, 89, 147-55.
14. Serafini MR, Santos RC, Guimarães AG, et al (2011). Morinda citrifolia Linn leaf extract possesses antioxidant activities and reduces nociceptive behavior and leukocyte migration. J Med Food, 14, 1159-66.
15. nd, Simone NL, Simone V, Simone CB (2007). Antioxidants and other nutrients do not interfere with chemotherapy or radioation therapy and can increase kill and increase survival. Part 1. Altern Ther Health Med, 13, 22-8.
16. Su BN, Pawlus AD, Jung HA, et al (2005). Chemical constituents of the fruits of morinda citrifolia (Noni) and their antioxidant activity. J Nat Prod, 68, 592-5.
17. Wang MY, Lutfiyya MN, Weidenbacher-Hoper V, et al (2009). Antioxidant activity of Noni juice in heavy smokers. Chem Cent J, 3, 13.
18. Wong YH, Abdul Kadir H (2012). Induction of mitochondria-mediated apoptosis in ca ski human cervical cancer cells triggered by mollic acid arabinoside isolated from leea indica. Evid Based Complement Alternat Med, 2012, 684-740.